4D Molecular Therapeutics, Inc.FDMTNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank13
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-159.55M
↓ 92% vs avg
Percentile
P13
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-83.00M
Historical baseline
PeriodValueYoY Change
2025$-159.55M+11.9%
2024$-181.14M-66.7%
2023$-108.66M-1.0%
2022$-107.63M-54.2%
2021$-69.81M-26.4%
2020$-55.22M-23.8%
2019$-44.62M-359.9%
2018$-9.70M+8.9%
2017$-10.65M-